Form4insider filings, from the source

SEC Form 4 · accession 0001044321-15-000048

Cellectar Biosciences, Inc. · CLRB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 3, 2015
Accepted (ET)
Feb 3, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2holding———1,142,368IBy Limited Partnerships

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF2,F3$1.00holding———Aug 15, 2014Feb 6, 2019Common Stock1,066,0001,066,000I

Explanation of responses